Protocol of Diuretics Use in Congestive Therapy in Heart Failure

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 299 participants.

Also called NCT03892148

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 299 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03892148
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03892148. Randomized; triple masking; primary purpose treatment. Start 2019-05-17 (actual); primary completion 2023-01-16 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Protocol of Diuretics Use in Congestive Therapy in Heart Failure
Acronym
ProDUCT-HF
Condition
Heart Failure
Condition
Acute Heart Failure
Condition
Chronic Heart Failure
Intervention (Drug)
Furosemide
Intervention (Drug)
Hydrochlorothiazide
Lead sponsor
University Hospital, Clermont-Ferrand (class: other)
Collaborator
University Hospital, Grenoble (class: other)
Collaborator
Hospices Civils de Lyon (class: other)
Collaborator
Hôpital de la Croix-Rousse (class: other)
Collaborator
CH Puy en Velay (class: not stated)
Collaborator
CH Moulins-Yzeure (class: not stated)
Collaborator
CH Riom (class: not stated)
Collaborator
Infirmerie Protestante de Lyon (class: other)
Collaborator
CH Issoire (class: not stated)
Collaborator
CH Annecy Genevois (class: other)

Record details

Record id
cardio:ct-nct03892148
Content hash
6151d6ad554224928d824da6678667102d39376e05294f3755bce92b702e042f